002793 罗欣药业
2024/03 - 三个月
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额(96,080)466,888(939,127)120,633(32,750)
投资活动产生之现金流量净额9,198957,426(119,182)(428,422)108,260
筹资活动产生之现金流量净额84,032(1,680,908)384,978789,533130,708
汇率变动对现金及现金等价物的影响1,4332,18014,099(1,132)(19,299)
现金及现金等价物净增加/(减少)(1,416)(254,413)(659,232)480,612186,919
期初现金及现金等价物余额579,942834,3551,493,5871,012,974826,055
期末现金及现金等价物余额578,525579,942834,3551,493,5871,012,974